Lightnews — Scholar-powered news

Sonobird - Clinical trial on recurrent glioblastoma

Carthera @carthera.bsky.social · 13d

The Sonobird trial is active in 40+ sites across Europe and the United States, evaluating whether adding SonoCloud‑guided BBB opening to carboplatin improves survival for patients with first‑recurrence grade glioblastoma.

Learn more about the trial👇
www.sonobird.eu

#glioblastoma #clinicaltrial

Find out more about the Sonobird clinical trial, combining ultrasound and carboplatin to treat recurrent glioblastoma. Contact a recruitment centre near you.

Sonobird - Clinical trial on recurrent glioblastoma

Carthera @carthera.bsky.social · 13d

Breaking Barriers: How Carthera’s SonoCloud Offers New Perspectives to Brain Cancer Patients 🧠

The American Brain Tumor Association has published an informative article for patients about our SonoCloud technology and how it's being used to treat glioblastoma.

www.abta.org/mindmatters/...

1 1

Carthera @carthera.bsky.social · 15d

In the meantime, you can learn about our Phase III trial, Sonobird on our dedicated website below👇
www.sonobird.eu

#glioblastoma #clinicaltrial #oncology #neurology #braincancer

Find out more about the Sonobird clinical trial, combining ultrasound and carboplatin to treat recurrent glioblastoma. Contact a recruitment centre near you.

Ancora - Find Cancer Clinical Trials

Carthera @carthera.bsky.social · 15d

🗓️ Meet the Carthera team from next week for the latest insights into our Phase III study evaluating SonoCloud 9 for #glioblastoma

🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19 [Booth 9]

💬 Drop by our booths or send us a DM to arrange a meeting

1 1

Carthera @carthera.bsky.social · 21d

Finding a #braintumor clinical trial can be overwhelming.

That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai

Ancora is a search tool that enables cancer patients to find relevant clinical trials in minutes. Radiopharmaceutical trial finder, nuclear medicine.

www.ancora.ai

SONOBIRD: a pivotal trial in recurrent glioblastoma

Carthera @carthera.bsky.social · Sep 9

In the meantime, you can learn about our Phase III trial, Sonobird, on our dedicated website below👇

www.sonobird.eu

#glioblastoma #clinicaltrial #oncology #neurology #braincancer

SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...

SONOBIRD: a pivotal trial in recurrent glioblastoma

Carthera @carthera.bsky.social · Sep 9

🗓️ Meet the Carthera team in October for the latest insights into our Phase III study evaluating SonoCloud‑9 for #glioblastoma

🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19

💬 Drop by our booths or send us a DM to arrange a meeting

1 2

Carthera @carthera.bsky.social · Sep 5

GLIOBLASTOMA TRIAL UPDATE 📣

Sonobird is now active in Denmark! 🇩🇰

Two weeks ago, the team at University of Copenhagen included the first Danish patient.

To learn more about the trial including active recruitment centres 👇
sonobird.eu

#Glioblastoma #ClinicalTrial #NeuroOncology

SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...

sonobird.eu

Carthera @carthera.bsky.social · Sep 2

🎙️ Our CSO Michael Canney was recently featured on the Med Tech Gurus podcast, where he dives into how our SonoCloud technology works and its potential to revolutionize glioblastoma care

www.youtube.com/watch?v=3kUF...

#NeuroOncology #ClinicalTrials #Glioblastoma #MedTech

Breaking Barriers

YouTube video by Med Tech Gurus

Carthera @carthera.bsky.social · Aug 28

Summer Review: Transforming Glioblastoma Treatment 🧠

🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma

Interviews & Podcast access 👉 linktr.ee/carthera

Brain Wellness - episode 145: Using ultrasound to treat glioblastoma with Michael Canney

Carthera @carthera.bsky.social · Aug 20

📣 Our CSO Michael Canney discussed our innovative approach to treating recurrent #glioblastoma on the Brain Wellness podcast. He explains how we use therapeutic ultrasound to enhance chemotherapy delivery to the brain.

www.youtube.com/watch?v=KcUu...

#MedTech #BrainCancer #ClinicalTrials

YouTube video by Brain Wellness NP

Carthera @carthera.bsky.social · Aug 13

📣 Our CSO, Michael Canney talks all things Sonobird on the Bindwaves podcast. Learn about SonoCloud-9, our ultrasound implant that disrupts the blood-brain barrier to enhance the delivery of therapeutic drugs.

www.youtube.com/watch?v=B2_D...

#Glioblastoma #BrainCancer #Oncology #ClinicalTrials

SONOBIRD: a pivotal trial in recurrent glioblastoma

Carthera @carthera.bsky.social · Aug 6

This trial involves 40+ clinical sites in the EU & US, evaluating our SonoCloud device to temporarily open the blood-brain barrier and enhance chemotherapy delivery for recurrent #glioblastoma patients

Learn more about the trial and clinical sites in Italy👇
sonobird.eu
#clinicaltrials #medtech

SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...

sonobird.eu

Carthera @carthera.bsky.social · Aug 6

📣 We’re thrilled to announce that our phase 3 trial for recurrent #glioblastoma has launched in Italy with the first patient enrolled in Bologna 🇮🇹

Prof. Giuseppe Lombardi, Italy’s referring investigator and site lead in Padua recently spoke about the trial.

Watch the interview👇
bit.ly/4msq3gX

Padova, un "device" a ultrasuoni per combattere il glioblastoma

Affidato allo Iov il coordinamento di un innovativo progetto internazionale per rendere molto più efficaci le terapie per contrastare questo aggressivo tumore cerebrale

bit.ly

Carthera @carthera.bsky.social · Aug 1

A new study has identified genes responsible for the spread of #glioblastoma, opening up new avenues for treatment. This breakthrough could pave the way for more effective therapies and improved patient outcomes.

Learn more👇
www.insideprecisionmedicine.com/topics/oncol...

#BrainTumor #Oncology

Genes Causing Spread of Glioblastoma Open Treatment Avenues

New research shows how glioblastoma cells infiltrate the brain and which key genes drive the invasion, paving the way to new treatments.

www.insideprecisionmedicine.com

Carthera @carthera.bsky.social · Jul 24

🧠 Purdue University Researchers Develop a Novel Human Brain Model to Study Alzheimer’s Disease

vet.purdue.edu/news/purdue-...

#Alzheimers

Purdue Researchers Develop a Novel Human Brain Model to Study Alzheimer's Disease

Purdue University College of Veterinary Medicine researchers are taking an innovative approach to studying Alzheimer’s disease. Dr. Ranjie Xu, an assistant professor in the Department of Basic Medical...

vet.purdue.edu

SONOBIRD: a pivotal trial in recurrent glioblastoma

Carthera @carthera.bsky.social · Jul 16

To learn more about our Sonobird trial, visit our dedicated website👇

www.sonobird.eu

#Glioblastoma #ClinicalTrial #Cancer #Oncology #MedTech

SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...

Glioblastoma Patient Joins the Sonobird Clinical Trial at UNC Health | Department of Neurosurgery

Carthera @carthera.bsky.social · Jul 16

🧠 On #GlioblastomaDay, we stand with the global call for better awareness, research & treatments.

Only four FDA-approved drugs & one device exist, we are working to change this through our SonoCloud system.

Read Lynn's story - a patient in our Sonobird trial👇
www.med.unc.edu/neurosurgery...

Lynn lives an active lifestyle as an owner of her own luxury traveling tours business. But when she got back from a corporate cruise in November of 2023, she started to feel sick every day. Lynn was q...

www.med.unc.edu

1 1

Carthera @carthera.bsky.social · Jul 9

🔊 New podcast!

Our CSO Dr. Michael Canney joins “Michael and Mom” to talk about the BBB, glioblastoma, and how SonoCloud is changing drug delivery to the brain.

Listen here: www.youtube.com/watch?v=lvRU...

#Glioblastoma #Oncology #ClinicalTrial

Michael & Mom Talk Glioblastoma Trial: Episode 63, Using Ultrasound to Break the Blood Brain Barrier

YouTube video by Michael and Mom Inspire

Carthera @carthera.bsky.social · Jul 1

Exciting news! Our SonoCloud is among the first devices to receive a positive opinion from the EMA expert panel for Orphan Medical Device status, targeting recurrent glioblastoma. A big step toward CE marking!

ala.associates/regulatory/c...

#Glioblastoma #Oncology #MedTech #NeuroOncology

S5:E78 Interview with Dr. Michael Canney

Carthera @carthera.bsky.social · Jun 26

Our CSO was recently featured on The Childhood Cancer Perspective

Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq...

#BrainCancerResearch #Glioblastoma #MedicalBreakthroughs

YouTube video by Battlecorn Care Packages